Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK/STAT3 signaling pathway
Arthritis Research & Therapy · 2024
DOI: 10.1186/s13075-024-03417-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Jeonghyeon Moon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Immunobiology and Neurology, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Osteoarthritis, Signal Transduction, STAT3 Transcription Factor, Mice, Inbred C57BL. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Drug Development Fund, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Objective
Osteoarthritis (OA) is a degenerative joint disease caused by the breakdown of joint cartilage and adjacent bone. Joint injury, being overweight, differences in leg length, high levels of joint stress, abnormal joint or limb development, and inherited factors have been implicated in the etiology of OA. In addition to physical damage to the joint, a role for inflammatory processes has been identified as well. Small heterodimer partner-interacting leucine zipper protein (SMILE) regulates transcription and many cellular functions. Among the proteins activated by SMILE is the peroxisome proliferator-activated receptor (PPAR) γ, which mediates the activities of CD4 + T helper cells, including Th1, Th2, and Th17, as well as Treg cells. PPAR-γ binds to STAT3 to inhibit its transcription, thereby suppressing the expression of the NF-κB pathway, and in turn, the expression of the inflammatory cytokines interferon (IFN), interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, which are sub-signals of STAT3 and NF-κB.
Methods
OA was induced in control C57BL/6 mice and in C57BL/6-derived SMILE-overexpressing transgenic (SMILE Tg) mice. The protein expression levels in the joint and spleen tissues were analyzed by immunohistochemistry and immunofluorescence images. In addition, flow cytometry was performed for detecting changes of the changes of immune cells.
Results
Less cartilage damage and significantly reduced levels of OA biomarkers (MMP13, TIMP3 and MCP-1) were observed in SMILE Tg mice. Immunohistochemistry performed to identify the signaling pathway involved in the link between SMILE expression and OA revealed decreased levels of IL-1β, IL-6, TNF-α, and phosphorylated AMPK in synovial tissues as well as a significant decrease in phosphorylated STAT3 in both cartilage and synovium. Changes in systemic immune cells were investigated via flow cytometry to analyze splenocytes isolated from control and SMILE Tg mice. SMILE Tg mice had elevated proportions of CD4 + IL-4 + cells (Th2) and CD4 + CD25 + Foxp3 + cells (Treg) and a notable decrease in CD4 + IL-17 + cells (Th17).
Conclusion
Our results show that overexpressed SMILE attenuates the symptoms of OA, by increasing AMPK signaling and decreasing STAT3, thus reducing the levels of inflammatory immune cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Immunobiology and Neurology, Yale School of Medicine, New Haven, CT, USA.
- Lab of Translational ImmunoMedicine (LaTIM), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
- Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, 06591, Korea.
- Department of Internal Medicine, and the Clinical Medicine Research Institute of Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon si, Gyeonggi-do, Korea.
- Institute of Medical Sciences, Canterbury Christ Church University, Medway Campus, Chatham, Kent, UK.
- Department of Internal Medicine, Division of Rheumatology, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, 222, Banpo‑daero, Seocho‑gu, Seoul, 06591, Korea.
Förderung
- Korea Drug Development Fund
- Korea Health Industry Development Institute
Zitieren
APA
Moon, J., Cho, K. H., Jhun, J., Choi, J., Na, H. S., Lee, J. S., Lee, S. Y., Min, J. K., Shetty, A., Park, S. H., Kim, S. J., & Cho, M. L. (2024). Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK/STAT3 signaling pathway. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03417-3
Vancouver
Moon J, Cho KH, Jhun J, Choi J, Na HS, Lee JS, et al. Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK/STAT3 signaling pathway. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03417-3
BibTeX
@article{Moon2024,
author = {Moon, Jeonghyeon and Cho, Keun-Hyung and Jhun, JooYeon and Choi, JeongWon and Na, Hyun-Sik and Lee, Jeong Su and Lee, Seung Yoon and Min, Jun-Ki and Shetty, Anan and Park, Sung-Hwan and Kim, Seok Jung and Cho, Mi-La},
title = {Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK/STAT3 signaling pathway},
journal = {Arthritis Research & Therapy},
year = {2024},
doi = {10.1186/s13075-024-03417-3}
}
EUVIMED